Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (591-600 of 927) with videos related to

Pageof 93
Sort By:
Circulation|December 1, 2025
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary SyndromeSotirios Tsimikas, Michael Szarek, Christa M Cobbaert, et al.
Stroke Research and Treatment|July 27, 2011
Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and MortalityStella Trompet, Douwe Pons, Sandip M Kanse, et al.
Diabetes Care|March 29, 2005
Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary interventionJamal S Rana, Pascalle S Monraats, Aeilko H Zwinderman, et al.
Circulation|August 12, 2009
p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activityClaudia M van Tiel, Peter I Bonta, Saskia Z H Rittersma, et al.
Atherosclerosis|February 12, 2008
Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly populationEliana Polisecki, Inga Peter, Michele Robertson, et al.
European Heart Journal|March 7, 2023
Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trialGregory G Schwartz, Michael Szarek, Deepak L Bhatt, et al.
European Journal of Human Genetics : EJHG|November 14, 2018
Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profileLisanne L Blauw, Raymond Noordam, Sebastian Soidinsalo, et al.
Thrombosis and Haemostasis|June 15, 2011
Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biologySeppo Ylä-Herttuala, Jacob Fog Bentzon, Mat Daemen, et al.
Atherosclerosis|May 13, 2014
In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER studyIris Postmus, Paul C D Johnson, Stella Trompet, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 5, 2025
Clinical and Technical Predictors of Treatment Success After Coronary Intravascular Lithotripsy in Calcific Coronary LesionsMartijn J H van Oort, Brian O Bingen, Federico Oliveri, et al.
Pageof 93

Showing results (591-600 of 927) with videos related to

Sort By:
Pageof 93
Circulation|December 1, 2025
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary SyndromeSotirios Tsimikas, Michael Szarek, Christa M Cobbaert, et al.
Stroke Research and Treatment|July 27, 2011
Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and MortalityStella Trompet, Douwe Pons, Sandip M Kanse, et al.
Diabetes Care|March 29, 2005
Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary interventionJamal S Rana, Pascalle S Monraats, Aeilko H Zwinderman, et al.
Circulation|August 12, 2009
p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activityClaudia M van Tiel, Peter I Bonta, Saskia Z H Rittersma, et al.
Atherosclerosis|February 12, 2008
Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly populationEliana Polisecki, Inga Peter, Michele Robertson, et al.
European Heart Journal|March 7, 2023
Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trialGregory G Schwartz, Michael Szarek, Deepak L Bhatt, et al.
European Journal of Human Genetics : EJHG|November 14, 2018
Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profileLisanne L Blauw, Raymond Noordam, Sebastian Soidinsalo, et al.
Thrombosis and Haemostasis|June 15, 2011
Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biologySeppo Ylä-Herttuala, Jacob Fog Bentzon, Mat Daemen, et al.
Atherosclerosis|May 13, 2014
In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER studyIris Postmus, Paul C D Johnson, Stella Trompet, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 5, 2025
Clinical and Technical Predictors of Treatment Success After Coronary Intravascular Lithotripsy in Calcific Coronary LesionsMartijn J H van Oort, Brian O Bingen, Federico Oliveri, et al.
Pageof 93